Academic Commons

Articles

Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo

Anastassiou, Dimitris; Rumjantseva, Viktoria; Cheng, Weiyi; Huang, Jianzhong; Canoll, Peter D.; Yamashiro, Darrell; Kandel, Jessica J.

Background: The biological mechanisms underlying cancer cell motility and invasiveness remain unclear, although it has been hypothesized that they involve some type of epithelial-mesenchymal transition (EMT). Methods: We used xenograft models of human cancer cells in immunocompromised mice, profiling the harvested tumors separately with species-specific probes and computationally analyzing the results. Results: Here we show that human cancer cells express in vivo a precise multi-cancer invasion-associated gene expression signature that prominently includes many EMT markers, among them the transcription factor Slug, fibronectin, and α-SMA. We found that human, but not mouse, cells express the signature and Slug is the only upregulated EMT-inducing transcription factor. The signature is also present in samples from many publicly available cancer gene expression datasets, suggesting that it is produced by the cancer cells themselves in multiple cancer types, including nonepithelial cancers such as neuroblastoma. Furthermore, we found that the presence of the signature in human xenografted cells was associated with a downregulation of adipocyte markers in the mouse tissue adjacent to the invasive tumor, suggesting that the signature is triggered by contextual microenvironmental interactions when the cancer cells encounter adipocytes, as previously reported. Conclusions: The known, precise and consistent gene composition of this cancer mesenchymal transition signature, particularly when combined with simultaneous analysis of the adjacent microenvironment, provides unique opportunities for shedding light on the underlying mechanisms of cancer invasiveness as well as identifying potential diagnostic markers and targets for metastasis-inhibiting therapeutics.

Files

  • thumnail for 1471-2407-11-529-S1.PDF 1471-2407-11-529-S1.PDF binary/octet-stream 127 KB Download File
  • thumnail for 1471-2407-11-529-S2.PDF 1471-2407-11-529-S2.PDF binary/octet-stream 65.8 KB Download File
  • thumnail for 1471-2407-11-529-S3.PDF 1471-2407-11-529-S3.PDF binary/octet-stream 51.7 KB Download File
  • thumnail for 1471-2407-11-529-S5.PDF 1471-2407-11-529-S5.PDF binary/octet-stream 287 KB Download File
  • thumnail for 1471-2407-11-529-S4.PDF 1471-2407-11-529-S4.PDF binary/octet-stream 70.8 KB Download File
  • thumnail for 1471-2407-11-529-S6.PDF 1471-2407-11-529-S6.PDF binary/octet-stream 72.6 KB Download File
  • thumnail for 1471-2407-11-529-S7.PDF 1471-2407-11-529-S7.PDF binary/octet-stream 100 KB Download File

Also Published In

More About This Work

Academic Units
Surgery
Pediatrics
Pathology and Cell Biology
Electrical Engineering
Publisher
BioMed Central
Published Here
September 9, 2014